Glimtos MP 1mg/500mg/15mg Tablet
Marketer
Medcure Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimtos MP 1mg/500mg/15mg Tablet
Metformin/Pioglitazone/Voglibose combination tablets (1mg/500mg/15mg) effectively manage blood glucose in adults with type 2 diabetes. This medication complements a healthy diet and exercise regimen to enhance glycemic control. It improves insulin utilization, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen. Take this medication with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose. Never double the dose. Excessive intake can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals may increase hypoglycemia risk. Regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician. Kidney function will be assessed before treatment initiation. Limit alcohol consumption to reduce the likelihood of adverse effects.
Primary Ingredients of Glimtos MP 1mg/500mg/15mg Tablet
No text was provided to rewrite.
Uses of Glimtos MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimtos MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Glimtos MP 1mg/500mg/15mg Tablet should be administered with food.
Common Side effects of Glimtos MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimtos MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glimtos MP 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with a meal.
How Glimtos MP 1mg/500mg/15mg Tablet works:
Glimtos MP tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity. Pioglitazone, a thiazolidinedione, further enhances insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Glimtos MP 1mg/500mg/15mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimtos MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimtos MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimtos MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimtos MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimtos MP 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimtos MP 1mg/500mg/15mg Tablet :
Should you forget a Glimtos MP 1mg/500mg/15mg Tablet dose, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimtos MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently